UNSPSC 51432500: Antihypertensive indoles

Antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.

UNSPSC 51432500 Antihypertensive indoles, a Class code, covers emergency-response medications and prescription pharmaceuticals that state and local governments procure for fire-rescue operations, public health agencies, and pharmacy benefit programs. State and local buyers under this code include city fire departments, state health and human services commissions, and cooperative purchasing alliances. The scope spans sealed competitive bids for specific medication units (such as Labetalol HCI vials and Diltiazem), cooperative multi-state pharmaceutical supply agreements with authorized wholesalers and manufacturers, and exploratory procurement mechanisms (RFIs) to establish direct-to-manufacturer prescription fulfillment channels that bypass traditional pharmacy benefit managers and group purchasing organizations.

Activity under this code spans Florida, Texas, and Minnesota. The City of Tampa Fire Rescue issued an IFB (Solicitation 26P00188) in April 2026 for Advanced Life Support Medications including 370 units of Labetalol HCI 100mg vials and 1,020 units of Diltiazem 25mg vials, with a response deadline of April 8, 2026 and an estimated contract value of $40,000.00, structured as a one-year term with renewal options and a Small Local Business Enterprise sheltered market set-aside with a 5 percent bid discount capped at $10,000. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802) due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., effective July 1, 2026, with contract terms of two years for new vendors and aligned expiration through June 30, 2028 for incumbents.